Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SAXAGLIPTIN vs SELENIUM SULFIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SAXAGLIPTIN vs SELENIUM SULFIDE: Safety Overview

Metric SAXAGLIPTIN SELENIUM SULFIDE
Total FAERS Reports 2,468 545
Deaths Reported 263 0
Death Rate 10.7% N/A
Hospitalizations 838 17
Average Patient Age 65.5 yrs 52.7 yrs
% Female Patients 47.8% 50.6%
FDA Approval Date Jul 31, 2009 Approved Prior to Jan 1, 1982
Manufacturer Glenmark Pharmaceuticals Inc., USA FAMILY DOLLAR SERVICES INC
Route ORAL TOPICAL
Marketing Status Discontinued Discontinued